Raise Money for Thyroid Cancer Treatment

PavelAndreev.ORG is an international crowdfunding platform for raising donations, through which thousands of charitable online campaigns have been organized. The platform is free for anyone who wants to start a campaign.

Start a campaign

How to start a thyroid cancer treatment fundraiser?

Your fundraiser on PavelAndreev.ORG starts in three quick and easy steps:

Create a campaign

Start your thyroid cancer treatment fundraising campaign in minutes with simple crowdfunding platform instructions.

Admin review & support

A platform administrator will review your thyroid cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your thyroid cancer treatment fundraising campaign on social media and receive donations from people who care.

Create a campaign

Start your thyroid cancer treatment fundraising campaign in minutes with simple crowdfunding platform instructions.

Admin review & support

A platform administrator will review your thyroid cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your thyroid cancer treatment fundraising campaign on social media and receive donations from people who care.

Start a campaign

Types of Medical Costs in Thyroid Cancer Treatment

  • Diagnostic & Screening Costs: Fine-needle aspiration (FNA) biopsy, diagnostic ultrasonography, pre-therapy whole-body scans (WBS), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET/CT), and routine biomarker testing (e.g., serum calcitonin, carcinoembryonic antigen [CEA], thyroglobulin [Tg], and anti-Tg antibodies).
  • Surgical Procedure Costs: Operative expenses for primary interventions, including thyroid lobectomy, total or near-total thyroidectomy, and central or lateral cervical lymph node dissections.
  • Radioactive Iodine (RAI) Therapy Costs: Remnant ablation, adjuvant radioactive iodine administration, pre-therapy dosimetry scans, and recombinant human TSH (rhTSH / thyrotropin alfa) administration.
  • Pharmacotherapy & Systemic Therapy Acquisition Costs: Lifelong hormone replacement/suppression therapy (e.g., levothyroxine), multikinase inhibitors (e.g., cabozantinib, lenvatinib, sorafenib, vandetanib), selective targeted inhibitors (e.g., selpercatinib, pralsetinib), cytotoxic chemotherapy, and bone-targeted agents (e.g., denosumab, zoledronic acid).
  • Routine Clinical & Laboratory Monitoring Costs: Complete blood counts (CBC), renal function testing, liver enzyme panels, serial electrocardiograms (ECGs), and periodic electrolyte assessments required during therapy or active surveillance.

  • Initial & Diagnostic Phase Costs: Expenses incurred during initial clinical workup, cytology, pathology evaluation, pre-operative staging, and initial risk stratification.
  • Primary / Acute Treatment Phase Costs: Inpatient hospital admissions, surgical operative care, immediate post-operative recovery, and initial therapeutic consolidation.
  • Long-Term Surveillance & Monitoring Phase Costs: Ongoing periodic neck ultrasonography, serial tumor marker testing, and routine surveillance imaging across post-treatment follow-up.
  • Progression & Second-Line Phase Costs: Management expenses following disease progression, second-line or subsequent systemic therapies, post-progression treatment continuation, and salvage interventions.

  • Geographic & Health System Regional Variations: Variations in national health insurance frameworks, regional practice patterns, and country-specific cost-effectiveness thresholds (e.g., United States vs. Japan vs. United Kingdom vs. Hong Kong).
  • Age-Related Coverage & Financial Burden Differences: Disparities in financial hardship between younger working-age populations and older adults with public insurance access (such as Medicare), alongside pediatric and adolescent care considerations.
  • Socioeconomic & Disparity-Linked Financial Costs: Financial toxicity, bankruptcy risk, employment loss or reduction, income loss, and food insecurity associated with socioeconomic status and specific racial/ethnic demographics.
  • Indirect Out-of-Pocket Expenses: Non-medical expenses borne by patients and families, including travel, lodging, childcare, lost wages, and unpaid sick leave for medical visits.

  • Primary Site & Locoregional Neck Compartment Costs: Surgical resections, local radiation, and diagnostic imaging directed at the primary organ site, central neck (level VI), and lateral neck (levels II–V) compartments.
  • Skeletal & Bone Metastases Costs: Management of bone metastases, skeletal-related events (SREs), pathologic fracture prevention/repair, spinal cord decompression, cementoplasty, stereotactic body radiation therapy (SBRT), and thermal ablation (RFA or cryoablation).
  • Visceral & Distant Organ Metastases Costs: Intervention and surveillance expenses for distant organ metastases, including pulmonary (lung), hepatic (liver), and brain/central nervous system (CNS) lesions.
  • Aerodigestive Tract Invasive Disease Costs: Invasive disease management costs for airway or upper gastrointestinal involvement, including tracheostomy, laser ablation, airway stenting, and percutaneous endoscopic gastrostomy (PEG) placement.

  • Active Surveillance vs. Immediate Surgery Costs: Comparative resource utilization between low-intensity serial observation protocols and upfront surgical resection (hemithyroidectomy/total thyroidectomy), including potential delayed conversion surgery.
  • Precision Oncology & Molecular Profiling Costs: Next-generation sequencing (NGS), multi-gene panel testing, and biomarker driver mutation profiling (e.g., BRAF, RET, NTRK, RAS, TERT, TP53) to guide targeted therapy selection.
  • Targeted & Redifferentiation Therapy Costs: Targeted small-molecule tyrosine kinase inhibitors, selective RET/NTRK inhibitors, BRAF/MEK combination regimens, and pre-RAI redifferentiation protocols.
  • Minimally Invasive Interventional Procedure Costs: Percutaneous thermal ablation techniques, including radiofrequency ablation (RFA), cryoablation, microwave ablation, and percutaneous ethanol injection (PEI).
  • Clinical Trial Participation Costs: Sponsor-covered investigational product costs balanced against non-reimbursed personal travel, scheduling, or protocol-mandated ancillary care expenses.

  • Lifelong Replacement & Supplementation Costs: Daily long-term levothyroxine administration for hormone suppression/replacement, alongside calcium and vitamin D supplementation for chronic post-surgical hypoparathyroidism.
  • Postoperative Complication Management Costs: Medical care for long-term surgical toxicities, such as recurrent laryngeal nerve palsy, chronic voice impairment/dysphonia, permanent hypocalcemia, and hematoma management.
  • Treatment Toxicity & Side Effect Management Costs: Clinical interventions for systemic therapy adverse events, including drug-induced hypertension, fatigue, diarrhea, mucocutaneous toxicities, cardiotoxicity, hepatotoxicity, nephrotoxicity, and osteonecrosis of the jaw.
  • Psychosocial & Survivorship Care Costs: Mental health support, counseling for cancer-related anxiety/depression ("scanxiety"), survivorship clinic visits, and quality-of-life maintenance programs.

  • Center & Provider Volume Operational Costs: Facility operational costs, hospital length-of-stay variations, and complication-related cost reductions associated with high-volume versus low-volume surgeons and medical centers.
  • Drug Access Schemes & Pricing Structure Costs: Institutional patient access schemes (PAS), commercial confidential discounts, dose adherence vs. relative dose intensity (RDI) adjustments, and drug wastage overhead.
  • Multidisciplinary Team (MDT) Infrastructure Costs: Institutional coordination for tumor boards, cross-specialty clinical consultations (endocrinology, surgery, nuclear medicine, radiology, oncology, pathology), and care navigator/social worker support.
  • Guideline Adaptation & Regulatory Compliance Overhead: Clinical practice guideline adaptation, registry data reporting, health technology assessment (HTA) compliance, and legal/malpractice risk management.

  • Symptom-Directed Palliative Procedure Costs: Localized palliative external beam radiation therapy (EBRT), stereotactic body radiation therapy (SBRT), cementoplasty, and interventional pain or bleeding control procedures.
  • Airway & Functional Palliation Costs: Emergency and supportive interventions to relieve aerodigestive compromise, such as airway stenting, tracheostomy, laser ablation, and gastrostomy tube placement.
  • Specialist Palliative & Hospice Service Costs: Inpatient or community-based hospice enrollment, palliative care specialist consultations, and end-of-life nursing care.
  • Palliative Pharmacotherapy & End-of-Life Support Costs: Pharmacological pain management, somatostatin analogs for severe hormonal symptoms/diarrhea, palliative cytotoxic chemotherapy for refractory disease, and advance care planning resources.

PavelAndreev.ORG results:

Donor trust and the security of funds on the platform are our highest priority. Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Total you have donated

49.57M EUR

Regardless of its size, every donation helps save a human life or successfully carry out a social cause.

Total number of donations

1 497 541

The contribution of a large number of people reflects the commitment of our society and contributes to the success of the campaigns.

Number of active campaigns

665

Every campaign is a unique cause and offers an opportunity to bring about positive change in our society.

Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Start a campaign

Three important reasons to start a campaign on PavelAndreev.ORG

At PavelAndreev.ORG we use new technologies to let you support fundraising campaigns quickly and easily.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Cancer statistics in the United States

Start a campaign
Start a campaign

PavelAndreev.ORG is a crowdfunding platform for organizing fundraising donation campaigns to raise money, managed by Foundation Pavel Andreev (UIC: 206678629) with founder and CEO Pavel Andreev. All donations made through the fundraising platform PavelAndreev.ORG are administered by the team of Pavel Andreev and the Foundation Pavel Andreev.

Google News: PavelAndreev.ORG, Pavel Andreev.